Allogeneic hematopoietic stem-cell transplantation may be performed using a nonmyeloablative regimen known as reduced-intensity conditioning.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Allogeneic hematopoietic stem-cell transplantation may be performed using a nonmyeloablative regimen known as reduced-intensity conditioning?

Yes. Reduced-intensity conditioning and nonmyeloablative regimens are widely recognized and utilized approaches for performing allogeneic hematopoietic stem-cell transplantation.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked 4 Oct 2026

The analysis

The claim states that allogeneic hematopoietic stem-cell transplantation may be performed using a nonmyeloablative regimen known as reduced-intensity conditioning. Multiple retrieved papers explicitly discuss and evaluate allogeneic hematopoietic stem-cell transplant protocols using reduced-intensity conditioning or nonmyeloablative conditioning, strongly supporting the claim without any refutation.

Evidence for · 3

Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.

2026

This study evaluates unrelated donor allogeneic hematopoietic cell transplantation utilizing reduced-intensity conditioning.

Get citation

Y, A., D, A., H, A., C, B., N, K., M, K., A, M., S, T., & RV, N. (2026). Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.. doi.org. https://doi.org/10.1016/j.jtct.2026.09.001

See more details

More for · 2

Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations.

2026

This review discusses nonmyeloablative and reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation.

Get citation

G, E., M, A., R, E. F., C, M. B. L., M, S., & M, A. J. (2026). Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations.. doi.org. https://doi.org/10.1038/s41409-026-02982-2

Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.

2026

This study discusses nonmyeloablative-related haploidentical allogeneic stem cell transplantation as a treatment option.

Get citation

K, C., S, I., DQ, N., M, S., D, W., HM, K., L, K., A, P., & G, G. (2026). Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.. doi.org. https://doi.org/10.1182/blood.2025032290

What does the evidence say?

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work